Tag
- Gilead Sciences Reports Q3 2023 Financial Results 2023-11-09
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- FDA Lifts Clinical Hold on Gilead's HIV Drug Lenacapavir 2022-05-18
- Gilead's CD47 Monoclonal Antibody Clinical Trial Was 'Unbloc... 2022-04-20
- Gilead: Remdesivir sold $1.93 billion in Q4 2021-02-08
- Sinopharm and Gilead announce cooperation 2020-09-14
- Pfizer signs deal to manufacture Gilead's remdesivir 2020-08-10
- Gilead announces results from Phase 3 Trial of remdesivir in... 2020-06-15
- Gilead may struggle to expand remdesivir's market to moderat... 2020-05-18
- Gilead's Japanese remdesivir nod, licensing talks; Lilly-Jun... 2020-05-09
Market Analysis
- Insufficient Cost and Demand Support; PTA Prices to Weaken Nov-15,2025
- Methanol Market Trends Weaken in China Nov-15,2025
- BDO Market Conditions Remain Stagnant and Consolidating Nov-15,2025
- Ethanol Market Prices Show Slight Fluctuations Nov-15,2025
- Ammonium Sulfate Market Prices Show a Small Increase (11.8-11.14) Nov-15,2025